BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
577 results:

  • 1. Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.
    Li T; Liu J; Zhou Y; Huang S; Wang D; Chen J; Fu Y; He P
    Cancer Med; 2024 May; 13(10):e7227. PubMed ID: 38770632
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
    Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
    J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Association of PD-L1 expression with driver gene mutations and clinicopathological characteristics in non-small cell lung cancer: A real-world study of 10 441 patients.
    Ruiz G; Enrico D; Mahmoud YD; Ruiz A; Cantarella MF; Leguina L; Barberis M; Beña A; Brest E; Starapoli S; Mendoza Bertelli A; Tsou F; Pupareli C; Coppola MP; Scocimarro A; Sena S; Levit P; Perfetti A; Aman E; Girotti MR; Arrieta O; Martín C; Salanova R
    Thorac Cancer; 2024 Apr; 15(11):895-905. PubMed ID: 38456253
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer.
    Ishida M; Iwasaku M; Doi T; Ishikawa T; Tachibana Y; Sawada R; Ogura Y; Kawachi H; Katayama Y; Nishioka N; Morimoto K; Tokuda S; Yamada T; Takayama K
    Cancer Sci; 2024 May; 115(5):1656-1664. PubMed ID: 38450844
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
    Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
    Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PD-L1 expression and its correlation with clinicopathological and molecular characteristics in Chinese patients with non-small cell lung cancer.
    Guo J; Yuan H; Zhu Y; Che Z; Zhang B; Zhang D; Zhou Y; Xiong L
    Medicine (Baltimore); 2024 Feb; 103(8):e36770. PubMed ID: 38394518
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fusion genes in pancreatic tumors.
    Gkountakos A; Singhi AD; Westphalen CB; Scarpa A; Luchini C
    Trends Cancer; 2024 May; 10(5):430-443. PubMed ID: 38378317
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
    Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
    Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy.
    Tomkins-Netzer O; Niederer R; Greenwood J; Fabian ID; Serlin Y; Friedman A; Lightman S
    Prog Retin Eye Res; 2024 Mar; 99():101245. PubMed ID: 38242492
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
    Kim JL; Gerrie AS; Savage KJ; Villa D; Scott D; Craig JW; Farinha P; Skinnider B; Slack G; Connors JM; Sehn LH; Venner C; Freeman CL
    Leuk Lymphoma; 2024 Mar; 65(3):346-352. PubMed ID: 38156444
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Kinase expression in angiomatoid fibrous histiocytoma: panTRK is commonly expressed in the absence of
    Vargas AC; Joy C; Maclean FM; Bonar F; Wong DD; Gill AJ; Cheah AL
    J Clin Pathol; 2024 Mar; 77(4):251-254. PubMed ID: 38053271
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Management of Brain Metastases: A Review of Novel Therapies.
    Bellur S; Khosla AA; Ozair A; Kotecha R; McDermott MW; Ahluwalia MS
    Semin Neurol; 2023 Dec; 43(6):845-858. PubMed ID: 38011864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circulating lung cancer biomarkers: From translational research to clinical practice.
    Qian X; Meng QH
    Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.
    Fulton-Ward T; Middleton G
    Ann Oncol; 2023 Dec; 34(12):1113-1130. PubMed ID: 37875224
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Intraoperative Integrated Diagnostic System for Malignant Central Nervous System Tumors.
    Hayashi T; Tateishi K; Matsuyama S; Iwashita H; Miyake Y; Oshima A; Honma H; Sasame J; Takabayashi K; Sugino K; Hirata E; Udaka N; Matsushita Y; Kato I; Hayashi H; Nakamura T; Ikegaya N; Takayama Y; Sonoda M; Oka C; Sato M; Isoda M; Kato M; Uchiyama K; Tanaka T; Muramatsu T; Miyake S; Suzuki R; Takadera M; Tatezuki J; Ayabe J; Suenaga J; Matsunaga S; Miyahara K; Manaka H; Murata H; Yokoyama T; Tanaka Y; Shuto T; Ichimura K; Kato S; Yamanaka S; Cahill DP; Fujii S; Shankar GM; Yamamoto T
    Clin Cancer Res; 2024 Jan; 30(1):116-126. PubMed ID: 37851071
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. KZ02 enhances the radiosensitivity of braf-mutated CRC in vitro and in vivo.
    Guo Y; Li X; Yuan R; Ren J; Huang Y; Yu Y; Tian H
    Eur J Pharmacol; 2023 Nov; 959():176060. PubMed ID: 37775019
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.
    Choi HY; Chang JE
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686423
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole blood.
    Ludvigsen LUP; Andersen AS; Hamilton-Dutoit S; Jensen-Fangel S; Bøttger P; Handberg KJ; Ivarsen P; d'Amore F; Bibby BM; Albertsen BK; Jespersen B; Thomsen MK
    J Clin Virol; 2023 Oct; 167():105579. PubMed ID: 37683299
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Rosai-Dorfman disease of the breast: a clinicoradiologic and pathologic study.
    Wang Q; Bradley K; Zhang M; Li S; Li X
    Hum Pathol; 2023 Nov; 141():30-42. PubMed ID: 37673345
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.